Gender-specific association of galanin polymorphisms with hpa-axis dysregulation, symptom severity, and antidepressant treatment response

Neuropsychopharmacology

Volumn 35, Issue 7, 2010, Pages 1583-1592

  Unschuld, Paul G ^a   Ising, Marcus ^a   Roeske, Darina ^a   Erhardt, Angelika ^a   Specht, Michael ^a   Kloiber, Stefan ^a   Uhr, Manfred ^a   Müller Myhsok, Bertram ^a   Holsboer, Florian ^a   Binder, Elisabeth B ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

Anxiety; Association; Depression; Galanin; Genetics; Response

Indexed keywords

ANTIDEPRESSANT AGENT; DEXAMETHASONE; GALANIN;

ADULT; ALLELE; ANXIETY DISORDER; ARTICLE; DISEASE SEVERITY; ESTROGEN RESPONSIVE ELEMENT; FEMALE; GENE LOCUS; GENOTYPE; HUMAN; HYPOTHALAMUS HYPOPHYSIS ADRENAL SYSTEM; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PREMENOPAUSE; PRIORITY JOURNAL; PROMOTER REGION; SEX DIFFERENCE; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE;

ADULT; ALZHEIMER DISEASE; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CORTICOTROPIN-RELEASING HORMONE; DEPRESSIVE DISORDER, MAJOR; DEXAMETHASONE; FEMALE; GALANIN; GENOME-WIDE ASSOCIATION STUDY; HORMONES; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; MALE; MIDDLE AGED; PITUITARY-ADRENAL SYSTEM; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS, GENETIC; SEVERITY OF ILLNESS INDEX; SEX CHARACTERISTICS;

EID: 77952332095     PISSN: 0893133X     EISSN: None     Source Type: Journal    
DOI: 10.1038/npp.2010.30     Document Type: Article

References (72)

1. Arvat E, Gianotti L, Ramunni J, Grottoli S, Brossa PC, Bertagna A et al (1995). Effect of galanin on basal and stimulated secretion of prolactin, gonadotropins, thyrotropin, adrenocorticotropin and cortisol in humans. Eur J Endocrinol 133: 300-304.
2. Bandelow B (1995). Assessing the efficacy of treatments for panic disorder and agoraphobia. II. The Panic and Agoraphobia Scale. Int Clin Psychopharmacol 10: 73-81.
3. Bardeleben U, Holsboer F (1989). Cortisol response to a combined dexamethasone-human corticotrophin-releasing hormone challenge in patients with depression. J Neuroendocrinol 1: 485-488.
4. Barrett JC, Fry B, Maller J, Daly MJ (2005). Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
5. Bartfai T, Lu X, Badie-Mahdavi H, Barr AM, Mazarati A, Hua XY et al (2004). Galmic, a nonpeptide galanin receptor agonist, affects behaviors in seizure, pain, and forced-swim tests. Proc Natl Acad Sci USA 101: 10470-10475.
6. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J (1961). An inventory for measuring depression. Arch Gen Psychiatry 4: 561-571.
7. Belfer I, Hipp H, Bollettino A, McKnight C, Evans C, Virkkunen M et al (2007). Alcoholism is associated with GALR3 but not two other galanin receptor genes. Genes Brain Behav 6: 473-481.
8. Belfer I, Hipp H, McKnight C, Evans C, Buzas B, Bollettino A et al (2006). Association of galanin haplotypes with alcoholism and anxiety in two ethnically distinct populations. Mol Psychiatry 11: 301-311.
9. Binder EB, Salyakina D, Lichtner P, Wochnik GM, Ising M, Putz B et al (2004). Polymorphisms in FKBP5 are associated with increased recurrence of depressive episodes and rapid response to antidepressant treatment. Nat Genet 36: 1319-1325.
10. Bland JM, Altman DG (1995). Multiple significance tests: the Bonferroni method. BMJ 310: 170.
11. Brann DW, Chorich LP, Mahesh VB (1993). Effect of progesterone on galanin mRNA levels in the hypothalamus and the pituitary: correlation with the gonadotropin surge. Neuroendocrinology 58: 531-538.
12. Britton KT, Lee G, Dana R, Risch SC, Koob GF (1986). Activating and 'anxiogenic' effects of corticotropin releasing factor are not inhibited by blockade of the pituitary-adrenal system with dexamethasone. Life Sci 39: 1281-1286.
13. Brogan RS, Coney LK, Wehrenberg WB, Beretta G, Giustina A (1999). Short-term glucocorticoid administration decreases both hypothalamic and pituitary galanin synthesis in the adult male rat. Metabolism 48: 792-796.
14. Ceccatelli S, Eriksson M, Hokfelt T (1989). Distribution and coexistence of corticotropin-releasing factor-, neurotensin-, enkephalin-, cholecystokinin-, galanin-and vasoactive intestinal polypeptide/peptide histidine isoleucine-like peptides in the parvocellular part of the paraventricular nucleus. Neuroendocri-nology 49: 309-323.
15. Consortium TIH (2003). The International HapMap project. Nature 426: 789-796.
16. Evans HF, Shine J (1991). Human galanin: molecular cloning reveals a unique structure. Endocrinology 129: 1682-1684.
17. Fava M, Hwang I, Rush AJ, Sampson N, Walters EE, Kessler RC (2009). The importance of irritability as a symptom of major depressive disorder: results from the national comorbidity survey replication. Mol Psychiatry (originally published online 10 March 2009; doi:10.1038/MP.2009.20).
18. Fuxe K, Jansson A, Diaz-Cabiale Z, Andersson A, Tinner B, Finnman UB et al (1998). Galanin modulates 5-hydroxytrypta-mine functions. Focus on galanin and galanin fragment/5-hydroxytryptamine1A receptor interactions in the brain. Ann N Y Acad Sci 863: 274-290.
19. Gentleman SM, Falkai P, Bogerts B, Herrero MT, Polak JM, Roberts GW (1989). Distribution of galanin-like immunoreactivity in the human brain. Brain Res 505: 311-315.
20. Hamilton M (1960). A rating scale for depression. J Neurol Neurosurg Psychiatry 23: 56-62.
21. Hemmer A, Hyde JF (1992). Regulation of galanin secretion from pituitary cells in vitro by estradiol and GHRH. Peptides 13: 1201-1206.
22. Hennings JM, Owashi T, Binder EB, Horstmann S, Menke A, Kloiber S et al (2009). Clinical characteristics and treatment outcome in a representative sample of depressed inpatientsF findings from the Munich Antidepressant Response Signature (MARS) project. J Psychiatr Res 43: 215-229.
23. Heuser I, Yassouridis A, Holsboer F (1994). The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders. J Psychiatr Res 28: 341-356.
24. Holmes PV, Blanchard DC, Blanchard RJ, Brady LS, Crawley JN (1995). Chronic social stress increases levels of preprogalanin mRNA in the rat locus coeruleus. Pharmacol Biochem Behav 50: 655-660.
25. Holsboer F (2000). The corticosteroid receptor hypothesis of depression. Neuropsychopharmacology 23: 477-501.
26. Hooi SC, Maiter DM, Martin JB, Koenig JI (1990). Galaninergic mechanisms are involved in the regulation of corticotropin and thyrotropin secretion in the rat. Endocrinology 127: 2281-2289.
27. Howard G, Peng L, Hyde JF (1997). An estrogen receptor binding site within the human galanin gene. Endocrinology 138: 4649-4656.
28. Ising M, Lucae S, Binder EB, Bettecken T, Uhr M, Ripke S et al (2009). A genome-wide association study points to multiple loci predicting antidepressant treatment outcome in depression. Arch Gen Psychiatry 66: 966-975.
29. Kaplan LM, Gabriel SM, Koenig JI, Sunday ME, Spindel ER, Martin JB et al (1988). Galanin is an estrogen-inducible, secretory product of the rat anterior pituitary. Proc Natl Acad Sci USA 85: 7408-7412.
30. Keck ME, Wigger A, Welt T, Muller MB, Gesing A, Reul JM et al (2002). Vasopressin mediates the response of the combined dexamethasone/CRH test in hyper-anxious rats: implications for pathogenesis of affective disorders. Neuropsychopharmacology 26: 94-105.
31. Kehr J, Yoshitake T, Wang FH, Razani H, Gimenez-Llort L, Jansson A et al (2002). Galanin is a potent in vivo modulator of mesencephalic serotonergic neurotransmission. Neuropsycho-pharmacology 27: 341-356.
32. Kessler RC, Chiu WT, Demler O, Merikangas KR, Walters EE (2005). Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication. Arch Gen Psychiatry 62: 617-627. (Pubitemid 40973437)
33. Khoshbouei H, Cecchi M, Dove S, Javors M, Morilak DA (2002a). Behavioral reactivity to stress: amplification of stress-induced noradrenergic activation elicits a galanin-mediated anxiolytic effect in central amygdala. Pharmacol Biochem Behav 71: 407-417.
34. Khoshbouei H, Cecchi M, Morilak DA (2002b). Modulatory effects of galanin in the lateral bed nucleus of the stria terminalis on behavioral and neuroendocrine responses to acute stress. Neuropsychopharmacology 27: 25-34. (Pubitemid 34626740)
35. Kofler B, Evans HF, Liu ML, Falls V, Iismaa TP, Shine J et al (1995). Characterization of the 5-flanking region of the human preprogalanin gene. DNA Cell Biol 14: 321-329.
36. Kunzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M et al (2003). Pharmacological and nonpharmacological factors influencing hypothalamic- pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test. Neuropsychopharmacology 28: 2169-2178.
37. Kuteeva E, Hokfelt T, Wardi T, Ogren SO (2008). Galanin, galanin receptor subtypes and depression-like behaviour. Cell Mol Life Sci 65: 1854-1863.
38. Landgraf R (2006). The involvement of the vasopressin system in stress-related disorders. CNS Neurol Disord Drug Targets 5: 167-179.
39. Leibowitz SF (1998). Differential functions of hypothalamic galanin cell grows in the regulation of eating and body weight. Ann N Y Acad Sci 863: 206-220.
40. Levran O, Londono D, O'Hara K, Nielsen DA, Peles E, Rotrosen J et al (2008). Genetic susceptibility to heroin addiction; a candidate-gene association study. Genes Brain Behav 7: 720-729.
41. Lopez FJ, Merchenthaler I, Ching M, Wisniewski MG, Negro-Vilar A (1991). Galanin: a hypothalamic-hypophysiotropic hormone modulating reproductive functions. Proc Natl Acad Sci USA 88: 4508-4512.
42. Ma X, Tong YG, Schmidt R, Brown W, Payza K, Hodzic L et al (2001). Effects of galanin receptor agonists on locus coeruleus neurons. Brain Res 919: 169-174.
43. Malendowicz LK, Nussdorfer GG, Nowak KW, Mazzocchi G (1994). The possible involvement of galanin in the modulation of the function of rat pituitary-adrenocortical axis under basal and stressful conditions. Endocr Res 20: 307-317.
44. Matthews KA, Meilahn E, Kuller LH, Kelsey SF, Caggiula AW, Wing RR (1989). Menopause and risk factors for coronary heart disease. N Engl J Med 321: 641-646.
45. Mazzocchi G, Malendowicz LK, Rebuffat P, Nussdorfer GG (1992). Effects of galanin on the secretory activity of the rat adrenal cortex: in vivo and in vitro studies. Res Exp Med (Berl) 192: 373-381.
46. Mechenthaler I (2008). Galanin and the neuroendocrine axes. Cell Mol Life Sci 65: 1826-1835.
47. Meczekalski B, Slopien R, Warenik-Szymankiewicz A (2001). The concentration of galanin in postmenopausal women before and after application of hormone replacement therapy compared to women of reproductive age. Med Sci Monit 7: 928-932.
48. Michener SR, Aimone LD, Yaksh TL, Go VL (1990). Distribution of galanin-like immunoreactivity in the pig, rat and human central nervous system. Peptides 11: 1217-1223.
49. Mitsukawa K, Lu X, Bartfai T (2008). Galanin, galanin receptors and drug targets. Cell Mol Life Sci 65: 1796-1805.
50. Murck H, Held K, Ziegenbein M, Kunzel H, Holsboer F, Steiger A (2004). Intravenous administration of the neuropeptide galanin has fast antidepressant efficacy and affects the sleep EEG. Psychoneuroendocrinology 29: 1205-1211.
51. Nemeroff CB, Owens MJ (2002). Treatment of mood disorders. Nat Neurosci 5(Suppl): 1068-1070.
52. O'Neal HA, Van Hoomissen JD, Holmes PV, Dishman RK (2001). Prepro-galanin messenger RNA levels are increased in rat locus coeruleus after treadmill exercise training. Neurosci Lett 299: 69-72.
53. Oquendo MA, Barrera A, Ellis SP, Li S, Burke AK, Grunebaum M et al (2004). Instability of symptoms in recurrent major depression: a prospective study. Am J Psychiatry 161: 255-261.
54. Ottlecz A, Snyder GD, McCann SM (1988). Regulatory role of galanin in control of hypothalamic-anterior pituitary function. Proc Natl Acad Sci USA 85: 9861-9865.
55. Pepin MC, Pothier F, Barden N (1992). Impaired type II glucocorticoid-receptor function in mice bearing antisense RNA transgene. Nature 355: 725-728.
56. Picciotto MR (2008). Galanin and addiction. Cell Mol Life Sci 65: 1872-1879.
57. Rhoades HM, Overall JE (1983). The Hamilton Depression Scale: factor scoring and profile classification. Psychopharmacol Bull 19: 91-96.
58. Ripke S (2007). WG-Permer: Rapid Analysis of Large Scale Whole Genome Association Studies. MPI of Psychiatry: Munich. http://www.wg-permer.org.
59. Rokaeus A, Brownstein MJ (1986). Construction of a porcine adrenal medullary cDNA library and nucleotide sequence analysis of two clones encoding a galanin precursor. Proc Natl Acad Sci USA 83: 6287-6291.
60. Schmidt WE, Kratzin H, Eckart K, Drevs D, Mundkowski G, Clemens A et al (1991). Isolation and primary structure of pituitary human galanin, a 30-residue nonamidated neuropep-tide. Proc Natl Acad Sci USA 88: 11435-11439.
61. Sharkey LM, Madamba SG, Siggins GR, Bartfai T (2008). Galanin alters GABAergic neurotransmission in the dorsal raphe nucleus. Neurochem Res 33: 285-291.
62. Stenzel-Poore MP, Heinrichs SC, Rivest S, Koob GF, Vale WW (1994). Overproduction of corticotropin-releasing factor in transgenic mice: a genetic model of anxiogenic behavior. J Neurosci 14(5 Pt 1): 2579-2584.
63. Strohle A, Poettig M, Barden N, Holsboer F, Montkowski A (1998). Age-and stimulus-dependent changes in anxiety-related behaviour of transgenic mice with GR dysfunction. Neuroreport 9: 2099-2102.
64. Sweerts BW, Jarrott B, Lawrence AJ (1999). Expression of preprogalanin mRNA following acute and chronic restraint stress in brains of normotensive and hypertensive rats. Brain Res Mol Brain Res 69: 113-123.
65. Tseng JY, Kolb PE, Raskind MA, Miller MA (1997). Estrogen regulates galanin but not tyrosine hydroxylase gene expression in the rat locus ceruleus. Brain Res Mol Brain Res 50: 100-106.
66. Tyszkiewicz JP, Fong TM, Dong Y (2008). GABAB receptors are required for galanin modulation of membrane properties of neurons in the arcuate nucleus of rats. Brain Res 1191: 63-68.
67. Unschuld PG, Ising M, Erhardt A, Lucae S, Kohli M, Kloiber S et al (2008). Polymorphisms in the galanin gene are associated with symptom-severity in female patients suffering from panic disorder. J Affect Disord 105: 177-184.
68. Vrontakis ME, Peden LM, Duckworth ML, Friesen HG (1987). Isolation and characterization of a complementary DNA (galanin) clone from estrogen-induced pituitary tumor messenger RNA. J Biol Chem 262: 16755-16758.
69. Westfall PH, Young SS (1993). Resampling-based Multiple Testing: Examples and Methods for p-value Adjustment. Wiley: New York.
70. Wittchen HU (1999). Screening for mental disorders: performance of the Composite International DiagnosticFScreener (CID-S). Int J Methods Psychiatr Res 8: 59-70.
71. Wrenn CC, Crawley JN (2001). Pharmacological evidence supporting a role for galanin in cognition and affect. Prog Neuropsycho-pharmacol Biol Psychiatry 25: 283-299.
72. Xu ZQ, Zhang X, Pieribone VA, Grillner S, Hokfelt T (1998). Galanin-5-hydroxytryptamine interactions: electrophysiological, immunohistochemical and in situ hybridization studies on rat dorsal raphe neurons with a note on galanin R1 and R2 receptors. Neuroscience 87: 79-94.